Puma Biotechnology
PBYI
PBYI
131 hedge funds and large institutions have $182M invested in Puma Biotechnology in 2025 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 121 → 131 (+10)
2.18% more ownership
Funds ownership: 66.05% → 68.23% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
131
Holding in Top 10
1
Calls
$1.73M
Puts
$1K
Top Buyers
| 1 | +$5.12M | |
| 2 | +$2.57M | |
| 3 | +$2.07M | |
| 4 |
Renaissance Technologies
New York
|
+$1.47M |
| 5 |
RWM
Ritholtz Wealth Management
New York
|
+$1.45M |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$1.74M | |
| 3 | -$1.37M | |
| 4 |
Millennium Management
New York
|
-$1.22M |
| 5 |
Two Sigma Advisers
New York
|
-$916K |
